Publications by authors named "Pierre Daumar"

Claim this Profile
D
Development of a liquid overlay-based three-dimensional cell culture panel for drug screening applications.
Marie Depresle, Pierre Daumar, Antoine Goisnard, Manon Roux, Corinne Aubel

Sci Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LightSpot Fluorescent Conjugates as Highly Efficient Tools for Lysosomal P-gp Quantification in Olaparib-Treated Triple-Negative Breast Cancer Cells.
Antoine Goisnard, Pierre Daumar, Maxime Dubois, Elodie Gay, Manon Roux

Int J Mol Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P-gp quantification for cell resistance studies in leukemia cells using the innovative LightSpot-FL-1 fluorescent conjugate.
Maxime Dubois, Antoine Goisnard, Céline Bourgne, Elodie Gay, Marie Depresle, Pierre Daumar

Sci Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a high-performance liquid chromatography method with fluorescence detection for the quantification of the resistance protein P-gp in cancer cells.
Elodie Gay, Maxime Dubois, Manon Roux, Antoine Goisnard, Marie Depresle, Pierre Daumar

J Chromatogr B Analyt Technol Biomed Life Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical biology fluorescent tools for investigation of the multidrug resistant P-glycoprotein (P-gp) expression in tumor cells.
Pierre Daumar, Antoine Goisnard, Clémence Dubois, Manon Roux, Marie Depresle

RSC Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LightSpot-FL-1 Fluorescent Probe: An Innovative Tool for Cancer Drug Resistance Analysis by Direct Detection and Quantification of the P-glycoprotein (P-gp) on Monolayer Culture and Spheroid Triple Negative Breast Cancer Models.
Antoine Goisnard, Pierre Daumar, Clémence Dubois, Corinne Aubel, Manon Roux

Cancers (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The New Serum-Free OptiPASS Medium in Cold and Oxygen-Free Conditions: An Innovative Conservation Method for the Preservation of MDA-MB-231 Triple Negative Breast Cancer Spheroids.
Antoine Goisnard, Clémence Dubois, Pierre Daumar, Corinne Aubel, Marie Depresle

Cancers (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose and Long-Term Olaparib Treatment Sensitizes MDA-MB-231 and SUM1315 Triple-Negative Breast Cancers Spheroids to Fractioned Radiotherapy.
Clémence Dubois, Fanny Martin, Chervin Hassel, Florian Magnier, Pierre Daumar

J Clin Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The New Synthetic Serum-Free Medium OptiPASS Promotes High Proliferation and Drug Efficacy Prediction on Spheroids from MDA-MB-231 and SUM1315 Triple-Negative Breast Cancer Cell Lines.
Clémence Dubois, Pierre Daumar, Corinne Aubel, Jean Gauthier, Bernard Vidalinc

J Clin Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a high-performance liquid chromatography method for the quantitation of intracellular PARP inhibitor Olaparib in cancer cells.
Pierre Daumar, Robin Dufour, Clémence Dubois, Frédérique Penault-Llorca, Mahchid Bamdad

J Pharm Biomed Anal· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and cytotoxic response of two proliferative MDA-MB-231 and non-proliferative SUM1315 three-dimensional cell culture models of triple-negative basal-like breast cancer cell lines.
Clémence Dubois, Robin Dufour, Pierre Daumar, Corinne Aubel, Claire Szczepaniak

Oncotarget· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCRP and P-gp relay overexpression in triple negative basal-like breast cancer cell line: a prospective role in resistance to Olaparib.
Robin Dufour, Pierre Daumar, Emmanuelle Mounetou, Corinne Aubel, Fabrice Kwiatkowski

Sci Rep· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of (18)F-labeled ATP competitive inhibitors of topoisomerase II as probes for imaging topoisomerase II expression.
Pierre Daumar, Brian M Zeglis, Nicholas Ramos, Vadim Divilov, Kuntal Kumar Sevak

Eur J Med Chem· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient (18)F-labeling of large 37-amino-acid pHLIP peptide analogues and their biological evaluation.
Pierre Daumar, Cindy A Wanger-Baumann, NagaVaraKishore Pillarsetty, Laura Fabrizio, Sean D Carlin

Bioconjug Chem· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and in vitro drug release investigation of new potential 5-FU prodrugs.
Pierre Daumar, Caroline Decombat, Jean-Michel Chezal, Eric Debiton, Michel Madesclaire

Eur J Med Chem· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The next generation of positron emission tomography radiopharmaceuticals in oncology.
Samuel L Rice, Celeste A Roney, Pierre Daumar, Jason S Lewis

Semin Nucl Med· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis